about
Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data.Gene sets identified with oncogene cooperativity analysis regulate in vivo growth and survival of leukemia stem cells.An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells.Interactions of Campylobacter jejuni cytolethal distending toxin subunits CdtA and CdtC with HeLa cellsDistinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia.Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.Matrix stiffening promotes a tumor vasculature phenotype.Acute myelogenous leukemia stem cells: from Bench to Bedside.Minimal residual disease in acute myelogenous leukemia.Campylobacter jejuni cytolethal distending toxin promotes DNA repair responses in normal human cellsCD25 expression and outcomes in older patients with acute myelogenous leukemia treated with plerixafor and decitabine.Oligomonocytic chronic myelomonocytic leukemia (chronic myelomonocytic leukemia without absolute monocytosis) displays a similar clinicopathologic and mutational profile to classical chronic myelomonocytic leukemia.The effect of initial molecular profile on response to recombinant interferon-α (rIFNα) treatment in early myelofibrosis.Identification of a nucleoside analog active against adenosine kinase-expressing plasma cell malignancies.Minimal Residual Disease Monitoring of Acute Myeloid Leukemia by Massively Multiplex Digital PCR in Patients with NPM1 Mutations.Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia.Chemical genomic screening reveals synergism between parthenolide and inhibitors of the PI-3 kinase and mTOR pathways.Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic Modifiers.Tat-calpastatin fusion proteins transduce primary rat cortical neurons but do not inhibit cellular calpain activity.Gene expression profiling using formalin-fixed paraffin-embedded primary specimens of AIDS-related Lymphomas
P50
Q31147913-C6097F4D-DAE8-414F-972D-D1C562C88B9DQ33622409-A89A294A-FC63-492D-AFB1-1AC28BA792B1Q34582568-FE425EA8-15DB-4AA2-A858-95FACAFA7B79Q35801898-3C76D3FD-83DF-4656-8355-797EA552B2FFQ37079676-18C0E463-B764-40E2-8955-0A5FC2D09103Q37259702-F8FCE84B-1240-4023-902C-E6B92EAD4859Q37598974-048EDC61-D929-4E58-BCD3-660BA5C16A56Q38020081-9AAA30E8-D7E3-490A-8336-3D5AFABE3151Q39266354-6CDA7235-5A93-4405-BF5A-55FA7DF90A54Q39707017-FB8D0FC7-88AA-4429-B62E-C4129C0A7ED9Q40118769-B7B13F4C-0F37-49DC-96B1-4F501CAABA58Q40184243-609351E8-D56F-45CC-B15D-FFC129CBF124Q40197045-DE00B36D-8C91-4F65-BF93-0A936932CE25Q40201379-AC7BB604-FFCD-42CB-B437-ABEFD1959E6EQ40471975-8235A370-5CCA-40F6-AF5D-E2D2D0DD1F38Q41769694-CC27B5B8-4CB6-4D63-AD80-B77D018D7794Q42871137-750D1DE4-CF00-4E6C-9730-903E55BB44FBQ45057071-5C8A0B35-A721-4BDA-9478-9AC497FF7B3DQ47360286-ACECE8B2-29CA-4AC4-9E62-07A69482B3BBQ59292200-9406D6BD-CE5E-459F-BC8C-0663E0C130DC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Duane Hassane
@ast
Duane Hassane
@en
Duane Hassane
@es
Duane Hassane
@nl
Duane Hassane
@sl
type
label
Duane Hassane
@ast
Duane Hassane
@en
Duane Hassane
@es
Duane Hassane
@nl
Duane Hassane
@sl
prefLabel
Duane Hassane
@ast
Duane Hassane
@en
Duane Hassane
@es
Duane Hassane
@nl
Duane Hassane
@sl
P106
P21
P31
P496
0000-0002-0719-9572
P569
2000-01-01T00:00:00Z